Related Experiment Video
Updated: May 6, 2026

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator
J Michael Younger1, Liling Chen, Hong-Yu Ren
1Department of Cell and Developmental Biology, UNC-Chapel Hill School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA.
Abstract:
Cystic fibrosis arises from the misfolding and premature degradation of CFTR Delta F508, a Cl- ion channel with a single amino acid deletion. Yet, the quality-control machinery that selects CFTR Delta F508 for degradation and the mechanism for its misfolding are not well defined. We identified an ER membrane-associated ubiquitin ligase complex containing the E3 RMA1, the E2 Ubc6e, and Derlin-1 that cooperates with the cytosolic Hsc70/CHIP E3 complex to triage CFTR and CFTR Delta F508. Derlin-1 serves to retain CFTR in the ER membrane and interacts with RMA1 and Ubc6e to promote CFTR's proteasomal degradation. RMA1 is capable of recognizing folding defects in CFTR Delta F508 coincident with translation, whereas the CHIP E3 appears to act posttranslationally. A folding defect in CFTR Delta F508 detected by RMA1 involves the inability of CFTR's second membrane-spanning domain to productively interact with amino-terminal domains. Thus, the RMA1 and CHIP E3 ubiquitin ligases act sequentially in ER membrane and cytosol to monitor the folding status of CFTR and CFTR Delta F508.
Insights
Cystic fibrosis involves misfolded CFTR Delta F508 protein. New research reveals RMA1 and CHIP E3 ubiquitin ligases sequentially target this defective protein for degradation, clarifying a key cellular quality control pathway.
Area of Science:
- Cellular Biology
- Protein Quality Control
- Molecular Mechanisms of Disease
Background:
- Cystic fibrosis is caused by misfolded CFTR Delta F508, a chloride ion channel.
- The cellular machinery responsible for CFTR Delta F508 degradation and misfolding mechanisms remain unclear.
Purpose of the Study:
- To identify the protein quality control machinery involved in CFTR Delta F508 degradation.
- To elucidate the sequential action of ubiquitin ligases in monitoring CFTR folding.
Main Methods:
- Investigated ER membrane-associated ubiquitin ligase complexes.
- Utilized co-immunoprecipitation and protein interaction studies.
- Analyzed the roles of RMA1, Ubc6e, Derlin-1, Hsc70, and CHIP in CFTR processing.
Main Results:
- Identified an ER complex (RMA1, Ubc6e, Derlin-1) and a cytosolic complex (Hsc70/CHIP) that triage CFTR and CFTR Delta F508.
- Derlin-1 retains CFTR in the ER membrane, facilitating degradation via RMA1 and Ubc6e.
- RMA1 recognizes co-translational folding defects, while CHIP acts post-translationally.
Conclusions:
- RMA1 and CHIP E3 ubiquitin ligases act sequentially in the ER membrane and cytosol.
- These ligases monitor the folding status of CFTR and CFTR Delta F508, targeting misfolded proteins for degradation.
- Understanding this pathway offers insights into cystic fibrosis pathogenesis.
More Related Videos
08:40Isokinetic Robotic Device to Improve Test-Retest and Inter-Rater Reliability for Stretch Reflex Measurements in Stroke Patients with Spasticity
Published on: June 12, 2019
05:56Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
Published on: September 6, 2024
Related Concept Videos
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Errors occurring during blood pressure monitoring
Several factors...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
Oxygen Delivering System III: Tracheostomy and T-piece
Tracheostomy
A tracheostomy is a surgically created opening (stoma) in the anterior part of the trachea. It is used to establish a patient airway, bypass an upper airway obstruction, simplify the removal of secretions, permit long-term...
Dysrhythmias VII: Nursing Management of Dysrhythmias
Continuous Renal Replacement Therapy